Alzheimer Society of Canada

Yesterday, Canadians across the country came together for our National Day of Action during Alzheimer’s Awareness Month, united by a simple but powerful message: no one should face dementia alone.

From sharing photos and wearing Forget-Me-Not pins to speaking up and challenging stigma, people across the country showed what collective action and community can look like. This important conversation was also amplified nationally through our appearance on Global News (bit.ly/4t808iy), helping bring greater awareness to the realities of dementia and the importance of support.

We’re deeply grateful to everyone who took part and helped remind people that the Alzheimer Society is always here — for individuals living with dementia, for caregivers, and for families. Thank you for standing with us, and for helping ensure we #ForgetNoOne 💙

On November 3, 2026 Canada's Drug Agency (CDA-AMC) issued a positive final recommendation to reimburse Kisunla® (donanemab) on public drug plans for eligible Canadians. This treatment is intended for Canadians living with mild cognitive impairment or mild dementia due to Alzheimer’s disease (early-stage Alzheimer’s disease). Donanemab is not a cure, but access to disease-modifying treatments may offer people living with Alzheimer's disease and care partners a new option, supporting efforts to maintain independence and quality of life for as long as possible.

Read more: bit.ly/4j7qvlR

--

Le 3 novembre 2026, l’Agence des médicaments du Canada (AMC) a émis une recommandation finale favorable au remboursement de Kisunla® (donanémab) par les régimes publics d’assurance-médicaments pour les personnes du Canada admissibles. Ce traitement est destiné aux personnes vivant avec un trouble cognitif léger ou un trouble neurocognitif attribuable à la maladie d’Alzheimer (stade léger de la maladie d’Alzheimer). Le donanémab n’est pas un remède curatif, mais l’accès à des traitements modificateurs de la maladie pourrait aider les personnes vivant avec la maladie d’Alzheimer à préserver leur autonomie et leur qualité de vie le plus longtemps possible.

En savoir plus: bit.ly/4AkdUBw

Yesterday, the federal government released Budget 2026 — including a proposal to make the existing Canada Caregiver Credit refundable. This will provide eligible care partners with up to $1,260 annually in new funds when they file their taxes. This is by no means insignificant, and we thank the federal government for recognizing this need. However, it does not resolve the broader financial pressures caregivers face.

Read our full response to Budget 2026 and what it means for people living with dementia and their care partners: bit.ly/4kBeLcq

--

Hier, le gouvernement fédéral a déposé son budget 2026, qui prévoit de rendre remboursable le crédit canadien pour aidant naturel existant. Elle permettra aux personnes admissibles de bénéficier d’un montant pouvant atteindre 1 260 $ par année lors de la production de leur déclaration de revenus. . Ces chiffres sont loin d’être négligeables, et nous remercions le gouvernement fédéral d’avoir reconnu ce besoin et d’avoir intégré le soutien aux partenaires de soins à ses priorités. Or, ce changement n’allège pas les pressions financières plus larges qui pèsent sur ces personnes.

Lisez la réponse de la Société Alzheimer du Canada au budget et découvrez ses répercussions sur les personnes vivant avec un trouble neurocognitif et leurs partenaires de soins: bit.ly/48zrGEC

#DementiaMatters #Budget2026 #canpoli

We can never recognize care partners enough.

Yesterday, MP Andréanne Larouche rose in the House of Commons to recognize the invaluable contributions of unpaid care partners and the challenges they face.

As the federal government prepares to unveil Budget 2026 tomorrow, we hope that recognition will be matched by meaningful action.

The Alzheimer Society of Canada has called on the federal government to implement the National Caregiving Strategy for Canada, including stronger financial supports, improved access to benefits and expanded employment protections for care partners.

Recognition matters. So does action.

#NationalCaregiversWeek

Want to know more about the work we do? Our 2025-2026 Annual Report, A New Horizon, is now available.

It looks back at a year of progress for people living with dementia and care partners: more than 150,000 client service interactions across the Alzheimer Society network, and 31 research projects funded through the Alzheimer Society Research Program, totalling $4.1 million.

Thank you to our donors, volunteers, researchers and partners for making this work possible.

“We’re not just dealing with the here and now. We’re changing the course of what this disease will look like in the future. That’s the horizon ahead of us.” Christina Scicluna — CEO, Alzheimer Society of Canada

Read the report: bit.ly/494Gg6F